Wealthking Investments Limited announced that effective 31 May 2023, Dr. Wang Qin (Dr. Wang) is appointed as a non-executive Director and the co-chairman (Co-Chairman) of the Board. Dr. Wang, aged 57, has over 30 years' experience in finance, investment and fund management. The major appointments of Dr. Wang include working at the Securities Department of Hainan Hong Kong and Macao International Trust Company Limited from 1991 to 1993; serving as the deputy general manager of Sanya Oriental Industrial Company Limited from 1993 to 1995; and serving as the head of the Research Department of Guosen Securities Co.

Ltd. from 1997 to 2001. From 2017 to 2020, Dr. Wang served as the general manager of ChiNext Qianhai Capital Co. Ltd. Dr. Wang has substantial fund management experience including working as the deputy general manager for Great Wall Fund Management Co., Limited from 2002 to 2009; as the general manager for Baoying Fund Management Co.

Ltd. from 2010 to 2016; and as the general manager for Changan Fund Management Co. Ltd. from 2021 to April 2023. Dr. Wang obtained a Bachelor's degree in Economics from Zhengzhou University in 1987; a Master's degree in Finance from the Graduate School of the People's Bank of China in 1991; a PhD degree in Economics from the Graduate School of the People's Bank of China in 1997; and an EMBA degree from the PBC School of Finance (PBCSF), Tsinghua University in 2018.

As a non-executive Director, Dr. Wang will not hold any management or executive role in the Company other than holding the office of non-executive Director and attending Board meetings. As the Co-Chairman of the Board, Dr. Wang will be mainly responsible for the strategic planning of the Company. Given Dr. Wang's extensive experience in finance, investment and fund management, the Board is confident that he will contribute enormous insight in the future development of the Company.